Integral Health Asset Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $8.31 Million - $10.9 Million	150,000 New	150,000 $8.82 Million
Q2 2023 Aug 11, 2023	BUY	$76.68 - $93.31 $5.52 Million - $6.72 Million	72,000 New	72,000 $6.56 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $1.3 Million - $2.03 Million	-29,150 Reduced 29.4%	70,000 $4.78 Million
Q2 2022 Aug 03, 2022	BUY	$35.07 - $59.21 $2.08 Million - $3.52 Million	59,381 Added 149.31%	99,150 $4.48 Million
Q1 2022 May 12, 2022	SELL	$35.46 - $54.12 $2.84 Million - $4.34 Million	-80,231 Reduced 66.86%	39,769 $2.02 Million
Q4 2021 Feb 02, 2022	SELL	$30.74 - $49.16 $2.15 Million - $3.44 Million	-70,000 Reduced 36.84%	120,000 $5.67 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $4.87 Million - $10.8 Million	155,000 Added 442.86%	190,000 $6.26 Million
Q2 2021 Aug 30, 2021	SELL	$40.9 - $64.9 $1.43 Million - $2.27 Million	-35,000 Reduced 50.0%	35,000 $2.21 Million
Q2 2021 Aug 13, 2021	BUY	$40.9 - $64.9 $2.86 Million - $4.54 Million	70,000 New	70,000 $4.42 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $2.77 Million - $5.15 Million	-90,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $2.33 Million - $3.03 Million	90,000 New	90,000 $2.72 Million
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $626,850 - $1.55 Million	-35,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$22.1 - $30.8 $773,500 - $1.08 Million	35,000 New	35,000 $1.07 Million

308

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.